Watchlist Price Alert

OptimizeRx Corporation (OPRX)

NASDAQ: OPRX · Real-Time Price · USD

12.17

0.74 (6.47%)

At close: May 19, 2025, 3:59 PM

12.53

2.96%

After-hours: May 19, 2025, 07:30 PM EDT

6.47% (1D)

Bid	11.95
Market Cap	225.09M
Revenue (ttm)	94.36M
Net Income (ttm)	-15.41M
EPS (ttm)	-0.84
PE Ratio (ttm)	-14.49
Forward PE	17.86
Analyst	Buy

Ask	12.78
Volume	605,390
Avg. Volume (20D)	567,354
Open	11.31
Previous Close	11.43
Day's Range	11.31 - 12.60
52-Week Range	3.78 - 13.33
Beta	1.28

About OPRX

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol OPRX

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for OPRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

OptimizeRx has released their quartely earnings on May 12, 2025:

Revenue of $21.93M exceeds estimates by $3.24M, with 11.37% YoY growth.

EPS of 0.08 exceeds estimates by 0.20, with 172.73% YoY growth.

Why Price Moved

1 week ago

+19.67%

OptimizeRx shares are trading higher after the com... Unlock content with Pro Subscription

6 days ago

-7.91%

OptimizeRx shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY25 sale guidance with its midpoint above estimates.

News

1 week ago · seekingalpha.com

OptimizeRx Corporation (OPRX) Q1 2025 Earnings Call Transcript

OptimizeRx Corporation (NASDAQ:OPRX ) Q1 2025 Earnings Conference Call May 12, 2025 4:30 PM ET Company Participants Steve Silvestro - Chief Executive Officer Edward Stelmakh - Chief Financial Officer ...

1 week ago · zacks.com

OptimizeRx Corp. (OPRX) Beats Q1 Earnings and Revenue Estimates

OptimizeRx Corp. (OPRX) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of a loss of $0.11 per share. This compares to loss of $0.11 per share a year ago.

2 months ago · benzinga.com

OptimizeRx Clocks Double-Digit Revenue Growth In Q4, Forecasts Sales Of At Least $100 Million

OPTIMIZERx Corp. OPRX, a health care technology firm, reported on Wednesday fourth-quarter sales of $32.32 million, up 14% year-over-year, beating the consensus of $30.36 million.

2 months ago · seekingalpha.com

OptimizeRx Corporation (OPRX) Q4 2024 Earnings Call Transcript

OptimizeRx Corporation (NASDAQ:OPRX ) Q4 2024 Results Conference Call March 12, 2025 8:30 AM ET Company Participants Steve Silvestro - President Edward Stelmakh - Chief Financial Officer and Chief Ope...

2 months ago · zacks.com

OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Beat Estimates

OptimizeRx Corp. (OPRX) came out with quarterly earnings of $0.30 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.26 per share a year ago.